Appendix 4E - 31 August 2010
VIR201 HIV Vaccine Phase IIa Trial Results - 16 August 2010
Positive effect of VIR201 HIV Vaccine published in AIDS Journal - 12 August 2010
Update on VIR201 HIV Vaccine Clinical Trial - 9 August 2010
Convertible Note Quarterly Report 30 June 2010
Update on VIR201 HIV Vaccine Clinical Trial - 7 July 2010
Appendix 3B - 18 June 2010
Chairman's Letter - Update May 2010 - 14 May 2010
Convertible Note Quarterly Report 31-03-2010
Transgene TG4010 Exclusive Option with Novartis - 11 Mar 2010
Appendix 3B and 3Y - 5 March 2010
Appointment of Director - Mr Tim Cooper - 1 Mar 2010
Appendix 4D 31 Dec 2009 - 26 Feb 2010
Notice of General Meeting 25 February 2010
Virax - Alpha Securities Report 11 February 2010
Notice of change in Substantial Shareholder - 9 Feb 2010
Appendix 3B and 3Y 1 February 2010
Rights Offer Update 28 January 2010
Notice of Initial Substantial Shareholder 20 Jan 2010
Rights Issues Closing Date and Status 15 Jan 2010
Convertable Note Quarterly Report 31 Dec 2009